Free Trial

AxoGen (AXGN) SEC Filings & 10K Form

AxoGen logo
$17.16 +0.26 (+1.54%)
Closing price 10/8/2025 04:00 PM Eastern
Extended Trading
$17.15 -0.01 (-0.06%)
As of 06:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AxoGen SEC Filings

DateFilerForm TypeView
10/07/2025
4:18 PM
AxoGen (Issuer)
Burke William P. Mr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2025
3:54 PM
AxoGen (Subject)
Burke William P. Mr. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/06/2025
3:54 PM
AxoGen (Issuer)
Burke William P. Mr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2025
3:36 PM
AxoGen (Subject)
Burke William P. Mr. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2025
3:29 PM
AxoGen (Subject)
Burke William P. Mr. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025
3:21 PM
AxoGen (Subject)
Burke William P. Mr. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025
3:24 PM
AxoGen (Subject)
Burke William P. Mr. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2025
4:22 PM
AxoGen (Issuer)
DeVinney Erick Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025
5:41 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025
3:52 PM
AxoGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2025
6:02 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
4:41 PM
AxoGen (Subject)
TYNDALL JOSEPH A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2025
3:32 PM
AxoGen (Issuer)
TYNDALL JOSEPH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:14 PM
AxoGen (Subject)
TYNDALL JOSEPH A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
5:47 PM
AxoGen (Issuer)
Hartley Lindsey Marie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2025
5:40 PM
AxoGen (Issuer)
Hartley Lindsey Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
3:42 PM
ArrowMark Colorado Holdings LLC (Filed by)
AxoGen (Subject)
Form SCHEDULE 13G/A
05/08/2025
6:10 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
6:07 AM
AxoGen (Filer)
Form DEF 14A
04/30/2025
6:09 AM
AxoGen (Filer)
Form ARS
04/07/2025
6:08 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
3:47 PM
AxoGen (Issuer)
Began Marc A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
3:48 PM
AxoGen (Issuer)
DALE MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
3:52 PM
AxoGen (Issuer)
DeVinney Erick Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
3:53 PM
AxoGen (Issuer)
Kemp Jens (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:24 PM
AxoGen (Issuer)
DeVinney Erick Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:49 PM
AxoGen (Issuer)
Kemp Jens (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:52 PM
AxoGen (Issuer)
Kemp Jens (Reporting)
Form 4/A
03/05/2025
5:24 PM
AxoGen (Issuer)
Began Marc A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:20 PM
AxoGen (Issuer)
Wendell Amy McBride (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:22 PM
AxoGen (Issuer)
DeVinney Erick Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:06 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
3:23 PM
AxoGen (Issuer)
DeVinney Erick Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:09 PM
AxoGen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:09 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
2:33 PM
AxoGen (Subject)
MORGAN STANLEY (Filed by)
Form SCHEDULE 13G/A
01/21/2025
12:20 PM
AxoGen (Subject)
Zaderej Karen L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
12:24 PM
AxoGen (Subject)
Zaderej Karen L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:01 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:35 PM
AxoGen (Subject)
First Light Asset Management, LLC (Filed by)
Form SCHEDULE 13G/A
01/06/2025
5:39 PM
AxoGen (Issuer)
Naor Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:40 PM
AxoGen (Issuer)
TYNDALL JOSEPH A. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
11/07/2024
9:52 AM
AxoGen (Subject)
Zaderej Karen L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:08 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AXGN) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners